© Copyright 2026 American Medical Association. All rights reserved.
Brain imaging using positron emission tomography (PET) is a sophisticated diagnostic procedure that allows for the visualization of metabolic processes in the brain. This technique employs a radiolabeled isotope tracer, commonly fluorodeoxyglucose (FDG), which is a glucose analog. The PET scan detects the emission of positrons from this radioactive substance, enabling the assessment of brain metabolism in real-time. The procedure generates three-dimensional (3-D) images that illustrate how different regions of the brain utilize glucose, which is crucial for understanding various neurological conditions. The varying uptake of the radiolabeled tracer by brain tissues is represented in the PET images through a spectrum of colors and brightness levels, indicating areas of high and low metabolic activity. To initiate the procedure, an intravenous line is established, and the radiolabeled tracer is injected into the patient's circulatory system. Following a specific waiting period to allow the tracer to localize in the brain, the patient is positioned on the imaging table, and the PET scanner is aligned over the head and neck to capture detailed tomographic views of the brain. The physician then interprets the resulting images and compiles a comprehensive written report detailing the findings of the metabolic evaluation.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.